Clinical Trial Update: Magnesium Sulfate in Neonatal HIE" [Phase 4]

View source ↗

Summary

Phase 4 trial update on magnesium sulfate use in neonates with hypoxic-ischemic encephalopathy (HIE).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy
• Neonatal Hypoxic-ischemic Brain Injury

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Sindh Institute of Child Health and Neonatology | Conditions: Neonates With HIE | Phase 4 | Status: UNKNOWN